Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
I was struggling with my health and even simple activities like traveling were becoming harder
Oral pain relievers provide systemic relief without this concern
Dietary Sources: Include B12-rich foods like fish, eggs, meat, and fortified plant-based milks in your diet
"Clinically, patients often describe feeling less hungry and more able to delay eating, particularly in the early part of the day," reveals Dr
[5] D eFoor MT, Dekker TJ